A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from wharton's jelly without enzymatic treatment

Stem Cells and Development

Volumn 20, Issue 3, 2011, Pages 547-557

  De Bruyn, Cécile ^a   Najar, Mehdi ^a   Raicevic, Gordana ^a   Meuleman, Nathalie ^a   Pieters, Karlien ^a   Stamatopoulos, Basile ^a   Delforge, Alain ^a   Bron, Dominique ^a   Lagneaux, Laurence ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN;

ARTICLE; CELL COUNT; CELL EXPANSION; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; STROMA CELL; UMBILICAL CORD;

ANTIGENS, DIFFERENTIATION; CALCIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; PHENOTYPE; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES; UMBILICAL CORD;

EID: 79952133607     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2010.0260     Document Type: Article

References (56)

1. Gluckman E. (2009). History of cord blood transplantation. Bone Marrow Transplant 44:621-626.
2. Wagner JE and E Gluckman. (2010). Umbilical cord blood transplantation: the first 20 years. Semin Hematol 47:3-12.
3. Noort WA, AB Kruisselbrink, PS Int Anker, M Kruger, RL van Bezooijen, RA de Paus, MH Heemskerk, CW Lowik, JH Falkenburg, R Willemze and WE Fibbe. (2002). Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34()cells in NOD=SCID mice. Exp Hematol. 30:870-878. (Pubitemid 34838889)
4. Angelopoulou M, E Novelli, JE Grove, HM Rinder, C Civin, L Cheng and DS Krause. (2003). Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD=SCID mice. Exp Hematol 31:413-420. (Pubitemid 36579367)
5. Bakhshi T, RC Zabriskie, S Bodie, S Kidd, S Ramin, LA Paganessi, SA Gregory, HC Fung and KW Christopherson. (2008). Mesenchymal stem cells from the Whartons jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture. Transfusion 48:2638-2644.
6. Gonzalo-Daganzo R, C Regidor, Martin-Donaire T, MA Rico, G Bautista, I Krsnik, R Forés, E Ojeda, I Sanjuán, JA García-Marco, B Navarro, S Gil, R Sánchez, N Panadero, Y Gutiérrez, M García-Berciano, N Pérez, I Millán, R Cabrera and MN Fernández. (2009). Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 11:278-288.
7. Sensebé L and P Bourin. (2009). Mesenchymal stem cells for therapeutic purposes. Transplantation. 87:S49-S53.
8. Bajada S, I Mazakova, JB Richardson and N Ashammakhi. (2008). Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2:169-183.
9. McElreavey KD, AI Irvine, KT Ennis and WH McLean. (1991). Isolation, culture and characterisation of fibroblastlike cells derived from the Whartons jelly portion of human umbilical cord. Biochem Soc Trans 19:29S.
10. Wang HS, SC Hung, ST Peng, CC Huang, HM Wei, YJ Guo, YS Fu, MC Lai and CC Chen. (2004). Mesenchymal stem cells in the Whartons jelly of the human umbilical cord. Stem Cells 22:1330-1337.
11. Can A and S Karahuseyinoglu. (2007). Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 25:2886-2895. (Pubitemid 350127873)
12. Karahuseyinoglu S, O Cinar, E Kilic, F Kara, GG Akay, DO Demiralp, A Tukun, D Uckan and A Can. (2007). Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25:319-331. (Pubitemid 46232786)
13. Pereira WC, I Khushnooma, M Madkaikar and K Ghosh. (2008). Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation. J Tissue Eng Regen Med 2:394-399.
14. Girdlestone J, VA Limbani, AJ Cutler and CV Navarrete. (2009). Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy 11:738-748.
15. Hou T, J Xu, X Wu, Z Xie, F Luo, Z Zhang and L Zeng. (2009). Umbilical cord Whartons Jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering. Tissue Eng Part A 15:2325-2334.
16. Weiss ML, C Anderson, S Medicetty, KB Seshareddy, RJ Weiss, I Vander Werff, D Troyer and KR McIntosh. (2008). Immune properties of human umbilical cord Whartons jelly-derived cells. Stem Cells 26:2865-2874.
17. Troyer DL and ML Weiss. (2008). Whartons jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591-599.
18. Sarugaser R, D Lickorish, D Baksh, MM Hosseini and JE Davies. (2005). Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23:220-229. (Pubitemid 40239517)
19. Lu LL, YJ Liu, SG Yang, QJ Zhao, X Wang, W Gong, ZB Han, ZS Xu, YX Lu, D Liu, ZZ Chen and ZC Han. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026.
20. Kadam SS, S Tiwari and RR Bhonde. (2009). Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord. In Vitro Cell Dev Biol Anim 45:23-27.
21. Nekanti U, VB Rao, AG Bahirvani, M Jan, S Totey and M Ta. (2010). Long-term expansion and pluripotent marker array analysis of Whartons jelly-derived mesenchymal stem cells. Stem Cells Dev.19:117-30.
22. La Rocca G, R Anzalone, S Corrao, F Magno, T Loria, Lo Iacono M, Di Stefano A, P Giannuzzi, L Marasà, F Cappello, G Zummo and F Farina. (2009). Isolation and characterization of Oct-4=HLA-G mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131:267-282.
23. Wu LF, NN Wang, YS Liu and X Wei. (2009). Differentiation of Whartons jelly primitive stromal cells into insulinproducing cells in comparison with bone marrow mesenchymal stem cells. Tissue Eng Part A 15:2865-2873.
24. Petsa A, S Gargani, A Felesakis, N Grigoriadis and I Grigoriadis. (2009). Effectiveness of protocol for the isolation of Whartons Jelly stem cells in large-scale applications. In Vitro Cell Dev Biol Anim 45:573-576.
25. Ishige I, Nagamura-Inoue T, MJ Honda, R Harnprasopwat, M Kido, M Sugimoto, H Nakauchi and A Tojo. (2009). Comparison of mesenchymal stem cells derived from arterial, venous, and Whartons jelly explants of human umbilical cord. Int J Hematol 90:261-269.
26. Mitchell KE, ML Weiss, BM Mitchell, P Martin, D Davis, L Morales, B Helwig, M Beerenstrauch, K Abou-Easa, T Hildreth, D Troyer and S Medicetty. (2003). Matrix cells from Whartons jelly form neurons and glia. Stem Cells 21:50-60. (Pubitemid 36120365)
27. Penolazzi L, R Vecchiatini, S Bignardi, E Lambertini, E Torreggiani, A Canella, T Franceschetti, G Calura, F Vesce and R Piva. (2009). Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells. Reprod Biol Endocrinol 7:106-112.
28. Moretti P, T Hatlapatka, D Marten, A Lavrentieva, I Majore, R Hass and C Kasper. (2009). Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applications. Adv Biochem Eng Biotechnol 123:29-54.
29. Magin AS, NR Ko rfer, H Partenheimer, C Lange, A Zander and T Noll. (2009). Primary cells as feeder cells for coculture expansion of human hematopoietic stem cells from umbilical cord blood-a comparative study. Stem Cells Dev 18:173-186.
30. Valencic E, E Piscianz, M Andolina, A Ventura and A Tommasini. (2010). The immunosuppressive effect of Whartons jelly stromal cells depends on the timing of their licensing and on lymphocyte activation. Cytotherapy 12:154-160.
31. Meloan SN, H Puchtler and LS Valentine. (1972). Alkaline and acid alizarin red S stains for alkali-soluble and alkaliinsoluble calcium deposits. Arch Pathol 93:190-197.
32. Metcalf D. (1998). Pre-progenitor cells: a proposed new category of hematopoietic precursor cells. Leukemia 12:1-3. (Pubitemid 28043757)
33. Gordon MY, CR Dowding, GP Riley and MF Greaves. (1987). Characterisation of stroma-dependent blast colonyforming cells in human marrow. J Cell Physiol 130:150-156. (Pubitemid 17011059)
34. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, DJ Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317. (Pubitemid 44269669)
35. Gluckman E, HA Broxmeyer, AD Auerbach, HS Friedman, GW Douglas, A Devergie, H Esperou, D Thierry, G Socie and P Lehn. (1989). Hematopoietic reconstitution in a patient with Fanconis anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174-1178. (Pubitemid 19255814)
36. Friedman R, M Betancur, L Boissel, H Tuncer, C Cetrulo and H Klingemann. (2007). Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant 13:1477-1486. (Pubitemid 350091385)
37. Le Blanc K, H Samuelsson, B Gustafsson, M Remberger, B Sundberg, J Arvidson, P Ljungman, H Lo nnies, S Nava and O Ringden. (2007). Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21:1733-1738. (Pubitemid 47086763)
38. Kim DW, YJ Chung, TG Kim, YL Kim and IH Oh. (2004). Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 103:1941-1948.
39. Macmillan ML, BR Blazar, TE DeFor and JE Wagner. (2009). Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood:results of a phase I-II clinical trial. Bone Marrow Transplant 43:447-454.
40. Lazarus HM, ON Koc, SM Devine, P Curtin, RT Maziarz, HK Holland, EJ Shpall, P McCarthy, K Atkinson, BW Cooper, SL Gerson, MJ Laughlin, FR Loberiza Jr., AB Moseley and A Bacigalupo. (2005). Cotransplantation of HLAidentical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389-398. (Pubitemid 40542932)
41. Mosna F, L Sensebé and M Krampera. (2010). Human bonemarrow and adipose tissue mesenchymal stem cells: a users guide. Stem Cells Dev 19:1449-1470.
42. Bieback K and H Klu ter. Mesenchymal stromal cells from umbilical cord blood. (2007). Curr Stem Cell Res Ther 2:310-323.
43. Harris DT. (2009). Non-haematological uses of cord blood stem cells. Br J Haematol 147:177-184.
44. Romanov YA, VA Svintsitskaya and VN Smirnov. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110. (Pubitemid 36120371)
45. Musina RA, ES Bekchanova, AV Belyavskii, TS Grinenko and GT Sukhikh. (2007). Umbilical cord blood mesenchymal stem cells. Bull Exp Biol Med 143:127-131. (Pubitemid 46784890)
46. Zeddou M, A Briquet, B Relic, C Josse, MG Malaise, A Gothot, C Lechanteur and Y Beguin. (2010). The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol Int 34:693-701.
47. Secco M, E Zucconi, NM Vieira, LL Fogaca, A Cerqueira, MD Carvalho, T Jazedje, OK Okamoto, AR Muotri and M Zatz. (2008). Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells 26:146-150.
48. Hung CT and RL Mauck. (2004). Biological assays: cellular level. In: Biomedical Technology and Devices Handbook. Moore JE, G Zouridakis, eds. CRS Press, London, pp 15:1-15:39.
49. Shetty P, K Cooper and C Viswanathan. (2010). Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian J Transfus Sci 4:14-24.
50. Wang L, I Tran, K Seshareddy, ML Weiss and MS Detamore. (2009). A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Eng Part A 8:2259-2266.
51. Zhang ZY, SH Teoh, MS Chong, JT Schantz, NM Fisk, MA Choolani and J Chan. (2009). Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 27:126-137.
52. Hsieh JY, YS Fu, SJ Chang, YH Tsuang and HW Wang. (2010). Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Whartons jelly of umbilical cord. Stem Cells Dev [Epub ahead of print].
53. Baksh D, R Yao and RS Tuan. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384-1392. (Pubitemid 47106005)
54. Karahuseyinoglu S, C Kocaefe, D Balci, E Erdemli and A Can. (2008). Functional structure of adipocytes differentiated from human umbilical cord stroma-derived stem cells. Stem Cells 26:682-691.
55. Rebelatto CK, AM Aguiar, MP Moreta o, AC Senegaglia, P Hansen, F Barchiki, J Oliveira, J Martins, C Kuligovski, F Mansur, A Christofis, VF Amaral, PS Brofman, S Goldenberg, LS Nakao and A Correa. (2008). Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med 233:901-913.
56. Najar M, G Raicevic, HI Boufker, HF Kazan, C De Bruyn, N Meuleman, D Bron, M Toungouz and L Lagneaux. (2010). Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Whartons jelly and bone marrow sources. Cellular Immunology 264:171-179.